Mycoplasma Pneumonia in Children

• 2020

  Log in to bookmark this resource.

  Log in
• Rebecca Raffler

---

Access Resources

• Job AidEN
• Ask aRCie About This Resource

About

The website describes Mycoplasma pneumonia in children, highlighting its rise after the COVID pandemic. It explains that Mycoplasma pneumoniae is a bacterium without a cell wall, making it resistant to certain antibiotics like penicillins. Symptoms include fever, cough, and fatigue; severe cases can lead to complications like respiratory failure. Diagnosis often involves PCR testing or antibody detection. Treatment usually includes macrolide antibiotics such as azithromycin. The article emphasizes the importance of choosing the right antibiotic for effective treatment and notes an increase in infections among young children aged 2-4 years in 2024.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Response

Keywords: Child; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Respiratory Tract Infections; Tetracyclines; Macrolides; Fluoroquinolones

Institutions: Atrium Health Carolinas Medical Center

---

More like this

Beginners Guide to NETEC (National Ebola Training and Education Center) Exercise Templates 2019 · National Emerging Pathogens Training & Education Center (NETEC) Talking with Parents about Vaccines 2024 · Centers for Disease Control and Prevention (CDC) Curriculum Recommendations for Disaster Health Professionals: Disaster Behavioral Health (2nd ed.) 2020 · National Center for Disaster Medicine and Public Health (NCDMPH), Uniformed Services University

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---